ResMed Stock - analyst consensus and background on the sleep-apnea specialist

ResMed stock remains a closely watched name in the medical-technology sector. With no fresh corporate news over the past 24 hours, Sunday’s focus turns to analyst consensus, valuation context and the fundamentals behind its sleep-apnea business.

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 08:07 CET. Details in the imprint.

ResMed Inc. (US7611521078) remains one of the larger pure-play sleep-apnea and respiratory-care names on the market. With no new filings or major news reported by leading wires in the past day, Sunday’s view centers on analyst consensus and the company’s longer-term positioning.

What current data show

ResMed stock is listed on the New York Stock Exchange under the ticker RMD and also trades on the Australian Securities Exchange under the code RMD, giving it a dual presence for US and Australian investors according to exchange data and company information. Company and exchange overview

Recent quote information from US trading shows the shares last closed at around $188.83 on 06/18/2026, highlighting a valuation that keeps the group firmly in large-cap territory in the medical-technology space. Latest market data snapshot

Analyst and consensus picture

Even without fresh weekend news, analyst coverage remains an important reference point. Market data aggregators indicate that several international houses continue to publish earnings estimates and target prices for ResMed, reflecting its role in the global sleep-apnea device market.

Consensus data from these platforms typically combine views on revenue growth from positive airway pressure devices and masks with expectations for the software and data segment, which management has emphasized in prior communications to investors.

The product behind the stock

ResMed generates most of its revenue from medical devices and digital solutions for sleep-disordered breathing, including continuous positive airway pressure systems and connected masks. Alongside hardware, the company also offers cloud-based software that supports sleep labs, homecare providers and patient adherence monitoring.

Where the stock trades today

The shares of ResMed Inc. (US7611521078) trade on the New York Stock Exchange under the ticker RMD, with the last verified closing price at $188.83 on 06/18/2026, 15:59 Eastern Time.

Key facts on ResMed stock

• Company: ResMed Inc.
• ISIN: US7611521078
• WKN: 895853
• Ticker: RMD
• Venue: NYSE
• Price (as of 06/18/2026, 15:59 ET): 188.83 USD
• Market cap: around 27,000,000,000 USD (as of mid-June 2026, based on recent share price and public share count)
• Sector / Industry: Health Care - Medical Equipment
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.